
Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study
Author(s) -
LC Coates,
Gladman Dd,
Peter Nash,
Oliver FitzGerald,
Arthur Kavanaugh,
Lawrence Rasouliyan,
Luminita Pricop,
Kevin Ding,
Corine Gaillez
Publication year - 2018
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.17
Subject(s) - secukinumab , psoriatic arthritis , medicine , phase (matter) , arthritis , dermatology , chemistry , organic chemistry
not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN